Vulvar Diseases D014845

Description

Pathological processes of the VULVA.   MeSH

Hierarchy View

Subtype Terms (5)

Pruritus Vulvae
1 approved drug

Vulvar Lichen Sclerosus
7 drugs (6 approved, 1 experimental)

Vulvar Neoplasms
63 drugs (38 approved, 25 experimental)

Vulvitis
 

Vulvodynia
20 drugs (17 approved, 3 experimental)


Approved Indicated Drugs (1)

Phase 2 Indicated Drugs (2)

Other Experimental Indicated Drugs (2)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 1 Indications (3)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.